Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype
Authors:
- Sabine KruegerSKSabine Krueger
- Udo KellnerUKUdo Kellner
- Frank BuehlingFBFrank Buehling
- Albert RoessnerARAlbert Roessner
- 1 July 2001
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (7) , 522-528
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 24 references indexed in Scilit:
- Unraveling the role of proteases in cancerClinica Chimica Acta, 2000
- Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissueEuropean Journal of Cancer, 1999
- Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profileJournal of Cancer Research and Clinical Oncology, 1998
- Prognostic significance of cathepsins B and L in primary human breast cancer.Journal of Clinical Oncology, 1998
- Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin CMelanoma Research, 1997
- Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64Clinical & Experimental Metastasis, 1997
- Cysteine proteases and tumor progressionPerspectives in Drug Discovery and Design, 1995
- Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growthJournal of Cancer Research and Clinical Oncology, 1994
- Biology and biochemistry of proteinases in tumor invasionPhysiological Reviews, 1993
- [41] Cathepsin B, cathepsin H, and cathepsin L1981